Análisis de la cuota de mercado y oportunidades de la terapia génica para enfermedades raras (2025-2031)
Gene Therapy For Rare Disease Market Report Analysis
Gene Therapy For Rare Disease Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- BioMarin
- Orchard Therapeutics plc.
- Spark Therapeutics, Inc.
- PTC Therapeutics
- bluebird bio, Inc.
- Kite Pharma
- uniQure N.V.
- Juno Therapeutics Inc. (Celgene Corporation)
- Novartis AG
Regional Overview
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Market Segmentation
By Aplicación Terapéutica
- Oncología
- Trastornos Neurológicos
- Trastornos Oftálmicos
- Trastornos Hematológicos
- Trastornos de Inmunodeficiencia
- Trastornos Metabólicos
- Otros
By Geografía
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
Get Free Sample For